Towards defining the role of drug eluting stents.
作者信息
Tarantini G, Ramondo A, Razzolini R
出版信息
Minerva Cardioangiol. 2008 Feb;56(1):29-34.
PMID:18432166
Abstract
摘要
相似文献
1
Towards defining the role of drug eluting stents.
Minerva Cardioangiol. 2008 Feb;56(1):29-34.
2
[Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
Kardiol Pol. 2005 Nov;63(5):574-6; discussion 577.
3
Percutaneous coronary intervention and drug-eluting stents.
CMAJ. 2005 Feb 1;172(3):323-5. doi: 10.1503/cmaj.1040945.
4
Understanding the drug-eluting stent trials.
Am J Cardiol. 2007 Sep 3;100(5A):17K-24K. doi: 10.1016/j.amjcard.2007.06.004. Epub 2007 Jun 26.
5
Drug-eluting stents: preventing restenosis.
Cardiol Rev. 2007 Jan-Feb;15(1):1-12. doi: 10.1097/01.crd.0000200844.16899.fc.
6
Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
J Am Coll Cardiol. 2007 Nov 20;50(21):2037-8. doi: 10.1016/j.jacc.2007.08.020. Epub 2007 Nov 5.
7
Drug-eluting stents.
J Invasive Cardiol. 2004 Jul;16(7 Suppl):2S-6S.
8
Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Cardiology. 2008;111(4):270-6. doi: 10.1159/000128602. Epub 2008 May 2.
9
Drug-eluting stents: the panacea for restenosis?
Singapore Med J. 2004 Jul;45(7):300-2.
10
Drug-eluting coronary stents.
N Engl J Med. 2005 Dec 1;353(22):2404-8; author reply 2404-8.
Zotero 插件